These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25767868)

  • 1. [Interview with PD Dr. Anton Gillessen, Münster. Non-alcoholic fatty liver: change in the life style!].
    Gillessen A
    MMW Fortschr Med; 2015 Jan; 157(1):69. PubMed ID: 25767868
    [No Abstract]   [Full Text] [Related]  

  • 2. Milk thistle to treat non-alcoholic fatty liver disease: dream or reality?
    Abenavoli L; Bellentani S
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):677-9. PubMed ID: 24134155
    [No Abstract]   [Full Text] [Related]  

  • 3. Phytotherapy and NAFLD--from goals and challenges to clinical practice.
    Milosević N; Milanović M; Abenavoli L; Milić N
    Rev Recent Clin Trials; 2014; 9(3):195-203. PubMed ID: 25514914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver diseases. Non-alcoholic fatty liver disease].
    Bernal Reyes R
    Rev Gastroenterol Mex; 2010 Aug; 75 Suppl 1():181-3. PubMed ID: 20959244
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of non-alcoholic fatty liver disease.
    Dyson J; Day C
    Dig Dis; 2014; 32(5):597-604. PubMed ID: 25034293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease in children and adolescents.
    Nobili V
    Clin Biochem; 2014 Jun; 47(9):720. PubMed ID: 24854694
    [No Abstract]   [Full Text] [Related]  

  • 7. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    ; LaBrecque DR; Abbas Z; Anania F; Ferenci P; Khan AG; Goh KL; Hamid SS; Isakov V; Lizarzabal M; Peñaranda MM; Ramos JF; Sarin S; Stimac D; Thomson AB; Umar M; Krabshuis J; LeMair A;
    J Clin Gastroenterol; 2014 Jul; 48(6):467-73. PubMed ID: 24921212
    [No Abstract]   [Full Text] [Related]  

  • 8. Fighting the fatty liver.
    Drew L
    Nature; 2017 Oct; 550(7675):S102-S103. PubMed ID: 29019968
    [No Abstract]   [Full Text] [Related]  

  • 9. Current solutions for obesity-related liver disorders: non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Raziel A; Sakran N; Szold A; Goitein D
    Isr Med Assoc J; 2015 Apr; 17(4):234-8. PubMed ID: 26040050
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease: a challenge for pediatricians.
    Nobili V; Alkhouri N; Alisi A; Della Corte C; Fitzpatrick E; Raponi M; Dhawan A
    JAMA Pediatr; 2015 Feb; 169(2):170-6. PubMed ID: 25506780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.
    Patel YA; Imperial JC; Muir AJ; Anstee QM; DeBrota D; Dimick-Santos L; Filozof C; Mehta R; Sanyal AJ; Schabel E; Neuschwander-Tetri BA; Miller V;
    Gastroenterology; 2017 Sep; 153(3):621-625.e7. PubMed ID: 28757264
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Trifolium pratense extract on methionine-choline-deficient diet-induced steatohepatitis in C57BL/6 mice.
    Chen T; Zhong FJ; Hong YM; Su WJ; Zhuang LL; Qiu LX
    Chin J Nat Med; 2014 Mar; 12(3):194-8. PubMed ID: 24702805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic Fatty Liver Disease: An Expanding Health Care Epidemic.
    Bernstein DE
    Clin Liver Dis; 2018 Feb; 22(1):xiii-xiv. PubMed ID: 29128064
    [No Abstract]   [Full Text] [Related]  

  • 14. Milk thistle (Silybum marianum) for the therapy of liver disease.
    Flora K; Hahn M; Rosen H; Benner K
    Am J Gastroenterol; 1998 Feb; 93(2):139-43. PubMed ID: 9468229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
    Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
    Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nutritional steatosis a drug target, or more especially anchor point for a holistic approach?].
    Couzigou P
    Presse Med; 2019 Oct; 48(10):1016-1018. PubMed ID: 31787171
    [No Abstract]   [Full Text] [Related]  

  • 17. [Weight loss can cure fatty liver].
    Füeßl HS
    MMW Fortschr Med; 2015 Sep; 157(16):38. PubMed ID: 26783621
    [No Abstract]   [Full Text] [Related]  

  • 18. Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease.
    Yilmaz Y; Senates E; Yesil A; Ergelen R; Colak Y
    J Diabetes Complications; 2014; 28(3):328-31. PubMed ID: 24602757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of fatty liver disease with the metabolic syndrome.
    Machado MV; Cortez-Pinto H
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):487-500. PubMed ID: 24665862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foreword. Nonalcoholic Fatty Liver Disease.
    Day CP; Anstee QM
    Semin Liver Dis; 2015 Aug; 35(3):203-6. PubMed ID: 26378638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.